White Paper: Redefining Fibroid Research with Human-Derived Cell Models

To advance fibroid research, Opal Therapeutics has developed lab-grown uterine organoids and cells from menstrual effluent and tissue biopsies. These models offer a suite of research tools to closely mimic how fibroids behave in the body and allow researchers to test how different drugs affect both healthy and fibroid-affected cells.